Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma

被引:11
|
作者
Berkowitz, Anne [1 ]
Walker, Suzanne [2 ]
机构
[1] Univ Penn, Hematol Bone Marrow Transplant Dept, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Penn Presbyterian Med Ctr, Philadelphia, PA USA
关键词
MANAGEMENT; THERAPY;
D O I
10.1188/12.CJON.86-89
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bortezomib-induced peripheral neuropathy (BIPN) often is difficult to manage or reverse once it occurs. Treatment usually involves dose-reduction, interruption, or cessation of therapy, as no other interventions have been proven effective. Oncology nurses must be vigilant and recognize BIPN early to prevent patients from experiencing symptoms and complications that may interfere with their quality of life.
引用
收藏
页码:86 / 89
页数:4
相关论文
共 50 条
  • [41] Genetic variation associated with bortezomib-induced peripheral neuropathy
    Favis, Reyna
    Sun, Yu
    van de Velde, Helgi
    Broderick, Erin
    Levey, Laura
    Meyers, Michael
    Mulligan, George
    Harousseau, Jean-Luc
    Richardson, Paul G.
    Ricci, Deborah S.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (03): : 121 - 129
  • [42] Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma
    Allegra, Alessandro
    Rizzo, Vincenzo
    Innao, Vanessa
    Alibrandi, Angela
    Mazzeo, Anna
    Leanza, Rossana
    Terranova, Carmen
    Gentile, Luca
    Girlanda, Paolo
    Allegra, Andrea
    Alonci, Andrea
    Musolino, Caterina
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (03) : 696 - 703
  • [43] Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy
    Zheng, H.
    Xiao, W. H.
    Bennett, G. J.
    EXPERIMENTAL NEUROLOGY, 2012, 238 (02) : 225 - 234
  • [44] Bortezomib-Induced Muscle Toxicity in Multiple Myeloma
    Guglielmi, Valeria
    Nowis, Dominika
    Tinelli, Martina
    Malatesta, Manuela
    Paoli, Laura
    Marini, Matteo
    Manganotti, Paolo
    Sadowski, Radoslaw
    Wilczynski, Grzegorz M.
    Meneghini, Vittorio
    Tomelleri, Giuliano
    Vattemi, Gaetano
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2017, 76 (07): : 620 - 630
  • [45] Bortezomib-induced Pneumonitis During Bortezomib Retreatment in Multiple Myeloma
    Yamaguchi, Takeshi
    Sasaki, Masaoki
    Itoh, Kuniaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (07) : 637 - 639
  • [46] Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients
    T Watanabe
    M Mitsuhashi
    M Sagawa
    M Ri
    K Suzuki
    M Abe
    K Ohmachi
    Y Nakagawa
    S Nakamura
    M Chosa
    S Iida
    M Kizaki
    Blood Cancer Journal, 2013, 3 : e150 - e150
  • [47] Phytohemagglutinin-induced IL2 mRNA in whole blood can predict bortezomib-induced peripheral neuropathy for multiple myeloma patients
    Watanabe, T.
    Mitsuhashi, M.
    Sagawa, M.
    Ri, M.
    Suzuki, K.
    Abe, M.
    Ohmachi, K.
    Nakagawa, Y.
    Nakamura, S.
    Chosa, M.
    Iida, S.
    Kizaki, M.
    BLOOD CANCER JOURNAL, 2013, 3 : e150 - e150
  • [48] Mechanistic Involvement of Inflammation in Bortezomib-induced Peripheral Neuropathy
    Goel, Lavisha
    Gupta, Pooja
    Pahuja, Monika
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (10) : 1595 - 1600
  • [49] Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain
    Zhi, W. Iris
    Ingram, Evan
    Li, Susan Qing
    Chen, Patricia
    Piulson, Lauren
    Bao, Ting
    INTEGRATIVE CANCER THERAPIES, 2018, 17 (04) : 1079 - 1086
  • [50] Bortezomib-induced peripheral neuropathy: facts and genes Reply
    Broyl, Annemiek
    Jongen, Joost L. M.
    Sonneveld, Pieter
    LANCET ONCOLOGY, 2011, 12 (02): : 121 - 121